A side-lined demonstration testing payment approaches for drugs that received accelerated approval could end up on the chopping block now that President Trump has rescinded a 2022 executive order by former President Biden intended to lower drug prices by developing payment models in Medicare and Medicaid.
Deciphering Trump’s Executive Order On Medicare, Medicaid Payment Models
Since CMMI does not need an executive order to conduct demonstrations, President Trump's executive order does not appear to mean the models developed under the Biden Administration will be suspended, yet.
